PF-00868554

DRUG2 trials

Sponsors

Pfizer

Conditions

Hepatitis C

Phase 1

A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients

CompletedNCT00445315

PfizerHepatitis C

Start: 2007-01-31End: 2008-06-30Updated: 2014-02-17

Phase 2

A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection

CompletedNCT00720434

PfizerHepatitis C

Start: 2008-08-31End: 2010-03-31Updated: 2013-08-26